Gary N. Gross

2.9k total citations
66 papers, 2.0k citations indexed

About

Gary N. Gross is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Gary N. Gross has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 21 papers in Immunology and Allergy. Recurrent topics in Gary N. Gross's work include Asthma and respiratory diseases (34 papers), Allergic Rhinitis and Sensitization (21 papers) and Respiratory and Cough-Related Research (16 papers). Gary N. Gross is often cited by papers focused on Asthma and respiratory diseases (34 papers), Allergic Rhinitis and Sensitization (21 papers) and Respiratory and Cough-Related Research (16 papers). Gary N. Gross collaborates with scholars based in United States, Germany and France. Gary N. Gross's co-authors include Alan K. Pierce, Galen B. Toews, Paul Chervinsky, Barbara A. Prillaman, Tushar Shah, Philip J. Thompson, Leslie Baitinger, Terje Lømo, O. Sveen and Craig LaForce and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and CHEST Journal.

In The Last Decade

Gary N. Gross

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary N. Gross United States 24 1.2k 1.1k 465 179 145 66 2.0k
H. J. Sluiter Netherlands 27 2.2k 1.9× 2.1k 2.0× 601 1.3× 261 1.5× 232 1.6× 67 3.5k
R.F. Lemanske United States 22 1.0k 0.9× 674 0.6× 414 0.9× 346 1.9× 492 3.4× 58 1.7k
Mario La Rosa Italy 27 909 0.8× 585 0.6× 949 2.0× 172 1.0× 216 1.5× 101 2.1k
Mark Schuyler United States 25 869 0.7× 1.5k 1.4× 224 0.5× 565 3.2× 254 1.8× 68 2.5k
Mauro Baldini United States 13 1.4k 1.2× 496 0.5× 451 1.0× 718 4.0× 214 1.5× 17 2.0k
Malcolm N. Blumenthal United States 26 1.2k 1.0× 385 0.4× 621 1.3× 565 3.2× 73 0.5× 71 2.1k
Lydiana Ávila Costa Rica 23 1.3k 1.1× 607 0.6× 321 0.7× 364 2.0× 185 1.3× 41 1.9k
Debra J. Turner Australia 24 893 0.8× 809 0.8× 251 0.5× 615 3.4× 139 1.0× 46 1.8k
Craig M. Schramm United States 26 1.1k 0.9× 1.0k 1.0× 226 0.5× 413 2.3× 133 0.9× 86 2.3k
Christian Fritzsch Germany 10 1.0k 0.9× 296 0.3× 436 0.9× 618 3.5× 77 0.5× 14 1.5k

Countries citing papers authored by Gary N. Gross

Since Specialization
Citations

This map shows the geographic impact of Gary N. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary N. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary N. Gross more than expected).

Fields of papers citing papers by Gary N. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary N. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary N. Gross. The network helps show where Gary N. Gross may publish in the future.

Co-authorship network of co-authors of Gary N. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Gary N. Gross. A scholar is included among the top collaborators of Gary N. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary N. Gross. Gary N. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meadows, J. Allen, Gary N. Gross, Anil Nanda, et al.. (2024). Guidance for the Evaluation by Payors of Claims Submitted Using Current Procedural Terminology Codes 95165, 95115, and 95117. The Journal of Allergy and Clinical Immunology In Practice. 13(1). 66–68.
2.
Amin, Nikhil, Leda Mannent, Claus Bachert, et al.. (2023). The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP. Rhinology Journal. 0(0). 0–0. 8 indexed citations
3.
Bielory, Leonard, et al.. (2020). Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate. Annals of Allergy Asthma & Immunology. 124(6). 616–621.e3. 1 indexed citations
4.
Chylack, Leo T., et al.. (2008). A Randomized, Controlled Trial to Investigate the Effect of Ciclesonide and Beclomethasone Dipropionate on Eye Lens Opacity. Journal of Asthma. 45(10). 893–902. 11 indexed citations
5.
Gross, Gary N., et al.. (2008). A serum sickness-like reaction to a commonly used acne drug. JAAPA. 21(3). 33–34. 3 indexed citations
6.
Yang, Guozhe, Mone Zaidi, Weijia Zhang, et al.. (2007). Functional grouping of osteoclast genes revealed through microarray analysis. Biochemical and Biophysical Research Communications. 366(2). 352–359. 23 indexed citations
7.
Huang, James, Yanping Zhong, Ken Gatter, et al.. (2005). Diagnostic Usefulness of Aberrant CD22 Expression in Differentiating Neoplastic Cells of B-Cell Chronic Lymphoproliferative Disorders From Admixed Benign B Cells in Four-Color Multiparameter Flow Cytometry. American Journal of Clinical Pathology. 123(6). 826–832. 2 indexed citations
8.
Tinkelman, David G., Edwin A. Bronsky, Gary N. Gross, William F. Schoenwetter, & Sheldon L. Spector. (2003). Efficacy and Safety of Budesonide Inhalation Powder (Pulmicort Turbuhaler®) During 52 Weeks of Treatment in Adults and Children with Persistent Asthma. Journal of Asthma. 40(3). 225–236. 11 indexed citations
9.
Nelson, Harold S., James Wolfe, Gary N. Gross, et al.. (2003). Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment. Annals of Allergy Asthma & Immunology. 91(3). 263–269. 30 indexed citations
10.
Finn, Albert F., Gary N. Gross, Julius van Bavel, et al.. (2003). Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. Journal of Allergy and Clinical Immunology. 111(2). 278–284. 140 indexed citations
11.
12.
Kavuru, Mani S., Julian Melamed, Gary N. Gross, et al.. (2000). Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 105(6). 1108–1116. 199 indexed citations
13.
Galant, Stanley P., Julius van Bavel, Albert F. Finn, et al.. (1999). Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Annals of Allergy Asthma & Immunology. 82(3). 273–280. 25 indexed citations
14.
Li, James T.C., Marc F. Goldstein, Gary N. Gross, et al.. (1999). Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. Journal of Allergy and Clinical Immunology. 103(4). 622–629. 25 indexed citations
15.
Schenkel, Eric, Gary N. Gross, Kraig W. Jacobson, et al.. (1997). Triamcinolone Acetonide Aqueous Nasal Inhaler for the Treatment of Spring Grass Seasonal Allergic Rhinitis in Children. Pediatric Asthma Allergy & Immunology. 11(2). 129–136. 7 indexed citations
16.
Neuber, K., Matthias Volkenandt, Markus Neumaier, et al.. (1996). B-Cell Chronic Lymphocytic Leukemia Associated with High Serum IGE Levels and Pruriginous Skin Lesions: Successful Therapy with IFN-α<sub>2b</sub> after Failure on IFN-&#947;. Dermatology. 192(2). 110–115. 8 indexed citations
17.
Wasserman, Stephen I., Gary N. Gross, William F. Schoenwetter, et al.. (1996). A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma. Journal of Asthma. 33(4). 265–274. 59 indexed citations
18.
Bardana, Emil J., Jonathan A. Bernstein, Joann Blessing-Moore, et al.. (1995). Practice parameters for the diagnosis and treatment of asthma. Journal of Allergy and Clinical Immunology. 96. 707–870. 67 indexed citations
19.
Gross, Gary N.. (1992). New Directions in Asthma Management. Southern Medical Journal. 85(6). 621–624.
20.
Miller, Jeffrey H, et al.. (1976). Altered RNA Polymerases Resulting from Temperature-sensitive Mutations in the rif Region of the E. coli Chromosome. Cold Spring Harbor Monograph Archive. 6. 519–538. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. J. Sluiter Breakdown of academic impact, for papers by R.F. Lemanske Breakdown of academic impact, for papers by Mario La Rosa Breakdown of academic impact, for papers by Mark Schuyler Breakdown of academic impact, for papers by Mauro Baldini Breakdown of academic impact, for papers by Malcolm N. Blumenthal Breakdown of academic impact, for papers by Lydiana Ávila Breakdown of academic impact, for papers by Debra J. Turner Breakdown of academic impact, for papers by Craig M. Schramm Breakdown of academic impact, for papers by Christian Fritzsch
Rankless by CCL
2026